Registry for collecting data on adult Acute Lymphoblastic Leukemia patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry collects prospective data on the diagnosis, treatment, and outcomes of adult patients with Acute Lymphoblastic Leukemia (ALL) and related diseases. It aims to improve research and quality assurance in the management of ALL by gathering information from clinical routines, regardless of whether patients are part of a clinical trial. The data collected will help in understanding treatment efficacy and patient outcomes over time.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Acute Lymphoblastic Leukemia (All Subtypes) if treated according to ALL protocols
* Other Types of Leukemia (NK Cell Lymphoma/Leukemia, Biphenotypic Acute Leukemia) if treated according to ALL protocols
* Non-Hodgkin's Lymphoma of Following Subtypes: Burkitt Lymphoma, B Cell Lymphoma, B- or T-lineage Lymphoblastic Lymphoma, Anaplastic Large Cell Lymphoma, Other NHL) if treated according to B-ALL protocols
* Age minimum 18 yrs

Where it's running

• Universitätsklinikum Graz
  Graz, Austria Recruiting
• LKH-Hochsteiermark Leoben
  Leoben, Austria Recruiting
• Ordensklinikum Linz Elisabethinen
  Linz, Austria Recruiting
• Universitätsklinikum St. Pölten
  Sankt Pölten, Austria Recruiting
• Hanusch-Krankenhaus Wien
  Vienna, Austria Recruiting
• University Hospital of Frankfurt (Main)
  Frankfurt am Main, Hesse, Germany Recruiting

+97 more sites. See ClinicalTrials.gov for the full list.

Study contacts

• Principal investigator: Nicola Gökbuget, Dr. med. — University Hospital of Frankfurt (Main)
• Study coordinator: Nicola Gökbuget, Dr. med.
• Email: goekbuget@em.uni-frankfurt.de
• Phone: +496963016365

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Strength Training for Kids with Acute Lymphoblastic Leukemia and Lymphoblastic L lymphoma

  Researchers are testing a structured strength-training program for children and teens recently diagnosed with ALL or lymphoblastic lymphoma to see if it helps with weight gain and physical function during treatment.

  Recruiting UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina · NCT07634653

• Cord blood transplant for children and young adults with blood cancers.

  This study will test whether a cord blood transplant given as a first or second transplant can help children and young adults with leukemia, myelodysplasia, or lymphoma who lack a matched donor.

  Recruiting Phase 2 Memorial Sloan Kettering Cancer Center · New York, New York · NCT07566377

• Revumenib with Mezigdomide for relapsed or refractory acute leukemia

  This trial will test whether combining revumenib and mezigdomide is safe for people aged 12 and older with relapsed or refractory acute leukemia that has KMT2A, NUP98, or NPM1 genetic changes.

  Recruiting at 7 sites Phase 1/2 Memorial Sloan Kettering Cancer Center · Duarte, California and 9 other locations · NCT07356154

• ALL Backbone in AYAs

  Aims to see if a chemotherapy regimen can safely and effectively treat newly diagnosed Philadelphia chromosome-negative ALL in adolescents and young adults.

  Recruiting Phase 2 Dana-Farber Cancer Institute · Boston, Massachusetts · NCT07227584

• Comparing antibiotics and immunoglobulin to prevent infections in blood cancers

  This project tests whether immunoglobulin or antibiotic strategies better prevent infections in adults with blood cancers.

  Recruiting at 3 sites Phase 2/3 Monash University · Adelaide, South Australia and 2 other locations · NCT07202052

• Using CD22 CAR T Cells after CD19 CAR T Cells for B Cell Leukemia

  This study is testing if giving CD22 CAR T-cell therapy to children and young adults with tough-to-treat B-cell leukemia after they’ve had another CAR T-cell treatment can be safe and effective.

  Recruiting Phase 1 Stanford University · Palo Alto, California · NCT06408194

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.